These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 21711151

  • 1. Description of primary multidrug-resistant tuberculous meningitis in an Italian child.
    Mauro MV, Cavalcanti P, Ledonne R, Giraldi C, Sperlì D.
    Microb Drug Resist; 2012 Feb; 18(1):71-3. PubMed ID: 21711151
    [Abstract] [Full Text] [Related]

  • 2. Drug susceptibility profiling of tuberculous meningitis.
    Nagarathna S, Rafi W, Veenakumari HB, Mani R, Satishchandra P, Chandramuki A.
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):105-7. PubMed ID: 18173886
    [Abstract] [Full Text] [Related]

  • 3. Isoniazid-resistant tuberculous meningitis, United States, 1993-2005.
    Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP.
    Emerg Infect Dis; 2011 Mar; 17(3):539-42. PubMed ID: 21392454
    [Abstract] [Full Text] [Related]

  • 4. Drug-resistant tuberculous meningitis.
    Garg RK, Jain A, Malhotra HS, Agrawal A, Garg R.
    Expert Rev Anti Infect Ther; 2013 Jun; 11(6):605-21. PubMed ID: 23750732
    [Abstract] [Full Text] [Related]

  • 5. Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis.
    Sharma K, Sharma M, Shree R, Singla N, Joshi H, Modi T, Goyal M, Sharma A, Sharma N, Modi M.
    Tuberculosis (Edinb); 2024 Jul; 147():102513. PubMed ID: 38547569
    [Abstract] [Full Text] [Related]

  • 6. Multi-drug resistant tuberculous meningitis.
    Kambli P, Nikam C, Shetty A, Soman R, Rodrigues C.
    Indian J Med Microbiol; 2016 Jul; 34(2):255. PubMed ID: 27080792
    [No Abstract] [Full Text] [Related]

  • 7. Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.
    Patel VB, Padayatchi N, Bhigjee AI, Allen J, Bhagwan B, Moodley AA, Mthiyane T.
    Clin Infect Dis; 2004 Mar 15; 38(6):851-6. PubMed ID: 14999630
    [Abstract] [Full Text] [Related]

  • 8. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun 15; 30(6):403-5. PubMed ID: 17673006
    [No Abstract] [Full Text] [Related]

  • 9. Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India.
    Gupta R, Thakur R, Kushwaha S, Jalan N, Rawat P, Gupta P, Aggarwal A, Gupta M, Manchanda V.
    Indian J Tuberc; 2018 Jan 15; 65(1):52-56. PubMed ID: 29332649
    [Abstract] [Full Text] [Related]

  • 10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 15; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 11. Comment on "Thwaites et al., 2005, The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis" J Infect Dis. 2005 Dec 15;192(12):2134-41.
    Dhasmana DJ, Davidson RN.
    J Infect; 2007 Feb 15; 54(2):205; author reply 206. PubMed ID: 16887190
    [No Abstract] [Full Text] [Related]

  • 12. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD.
    Microb Drug Resist; 2010 Mar 15; 16(1):21-8. PubMed ID: 20001742
    [Abstract] [Full Text] [Related]

  • 13. Concomitant multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis.
    Bernard C, Brossier F, Fréchet-Jachym M, Morand PC, Coignard S, Aslangul E, Aubry A, Jarlier V, Sougakoff W, Veziris N.
    Emerg Infect Dis; 2014 Mar 15; 20(3):506-7. PubMed ID: 24565423
    [No Abstract] [Full Text] [Related]

  • 14. Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
    Morales Pérez C, Gomez-Pastrana D, Aragón Fernández C, Pérez Escolano E.
    Arch Bronconeumol (Engl Ed); 2019 Jul 15; 55(7):388-390. PubMed ID: 30635203
    [No Abstract] [Full Text] [Related]

  • 15. Tuberculous meningitis--a case report.
    Guziejko K, Czupryna P, Moniuszko A, Grygorczuk S, Kondrusik M, Zajkowska J, Pancewicz S.
    Przegl Epidemiol; 2013 Jul 15; 67(4):629-32, 717-9. PubMed ID: 24741908
    [Abstract] [Full Text] [Related]

  • 16. The new nodular lesions at the brain base.
    Chang HT, Kuo YW, Lin CH, Jerng JS.
    Clin Infect Dis; 2011 Aug 01; 53(3):295, 303-4. PubMed ID: 21765080
    [No Abstract] [Full Text] [Related]

  • 17. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA, Farnia P, Masjedi MR, Hoffner S.
    Int J Tuberc Lung Dis; 2013 Jun 01; 17(6):849-50. PubMed ID: 23676176
    [No Abstract] [Full Text] [Related]

  • 18. Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.
    Padayatchi N, Bamber S, Dawood H, Bobat R.
    Pediatr Infect Dis J; 2006 Feb 01; 25(2):147-50. PubMed ID: 16462292
    [Abstract] [Full Text] [Related]

  • 19. Isoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment.
    Abate D, Tedla Y, Meressa D, Ameni G.
    Int J Tuberc Lung Dis; 2014 Aug 01; 18(8):946-51. PubMed ID: 25199009
    [Abstract] [Full Text] [Related]

  • 20. Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
    Ho PL, Yam WC, Leung CC, Yew WW, Mok TY, Chan KS, Tam CM.
    Hong Kong Med J; 2015 Jun 01; 21 Suppl 4():4-7. PubMed ID: 26157093
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.